Difference between revisions of "Part:BBa K3140002"
Line 11: | Line 11: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | + | The mechanism of psilocybin biosynthesis in ''Psilocybe'' sp. was recently elucidated by Fricke ''et al''.<ref name="Fricke">Fricke, J., Blei, F. & Hoffmeister, D. Enzymatic Synthesis of Psilocybin. ''Angew Chem Int Ed Engl'' '''56''', 12352-12355 (2017).</ref>, demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin. | |
− | + | PsiK is a native enzyme obtained from ''Psilocybe cubensis'', which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin ('''Fig. 1''') and psilocybin ('''Fig. 2'''), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool<ref name="ExPASy">Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. ''Nucleic Acids Res'' '''40''', W597-603 (2012).</ref>. | |
− | [[Image:T--Sydney_Australia-- | + | [[Image:T--Sydney_Australia--PsiK_KEGG_rxn1.gif|frame|none|Fig. 1: Phosphorylation of 4-hydroxytryptamine to norbaeocystin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R11933 KEGG] ]] |
+ | [[Image:T--Sydney_Australia--PsiK_KEGG_rxn2.gif|frame|none|Fig. 2: Phosphorylation of psilocin to psilocybin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R08480 KEGG] ]] | ||
+ | |||
+ | Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into ''Escherichia coli'' BL21(DE3), co-transformed with chaperone plasmid pGro7 ('''Fig. 3'''), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa. | ||
− | |||
− | |||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> |
Revision as of 03:54, 15 October 2019
PsiK - 4-hydroxytryptamine kinase from Psilocybe cubensis
PsiK is a 4-hydroxytryptamine kinase, which catalyses the conversion of 4-hydroxytryptamine to norbaeocystin.
- NCBI: ASU62237.1
- UniProt: P0DPA8
- EC number: 2.7.1.222
Usage and Biology
The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
PsiK is a native enzyme obtained from Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin (Fig. 1) and psilocybin (Fig. 2), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool[2].
Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 864
Illegal SapI.rc site found at 973